- Home
- RARE vs ANF Comparison
RARE vs ANF Comparison
Compare RARE & ANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- ANF
- Stock Information
- Founded
- RARE 2010
- ANF 1892
- Country
- RARE United States
- ANF United States
- Employees
- RARE N/A
- ANF N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- ANF Clothing/Shoe/Accessory Stores
- Sector
- RARE Health Care
- ANF Consumer Discretionary
- Exchange
- RARE Nasdaq
- ANF Nasdaq
- Market Cap
- RARE 3.5B
- ANF 3.7B
- IPO Year
- RARE 2014
- ANF 1996
- Fundamental
- Price
- RARE $35.80
- ANF $85.45
- Analyst Decision
- RARE Strong Buy
- ANF Buy
- Analyst Count
- RARE 15
- ANF 10
- Target Price
- RARE $90.53
- ANF $118.56
- AVG Volume (30 Days)
- RARE 1.1M
- ANF 2.1M
- Earning Date
- RARE 07-31-2025
- ANF 08-27-2025
- Dividend Yield
- RARE N/A
- ANF N/A
- EPS Growth
- RARE N/A
- ANF 27.29
- EPS
- RARE N/A
- ANF 10.18
- Revenue
- RARE $590,689,000.00
- ANF $5,025,168,000.00
- Revenue This Year
- RARE $18.94
- ANF $5.93
- Revenue Next Year
- RARE $28.93
- ANF $3.07
- P/E Ratio
- RARE N/A
- ANF $8.20
- Revenue Growth
- RARE 33.46
- ANF 12.54
- 52 Week Low
- RARE $29.59
- ANF $65.40
- 52 Week High
- RARE $60.37
- ANF $186.45
- Technical
- Relative Strength Index (RSI)
- RARE 43.91
- ANF 63.34
- Support Level
- RARE $35.59
- ANF $75.05
- Resistance Level
- RARE $38.19
- ANF $80.71
- Average True Range (ATR)
- RARE 1.50
- ANF 2.88
- MACD
- RARE -0.17
- ANF 0.69
- Stochastic Oscillator
- RARE 4.57
- ANF 98.97
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About ANF Abercrombie & Fitch Company
Abercrombie & Fitch Co is a specialty retailer that sells casual clothing, personal-care products, and accessories for men, women, and children. It sells direct to consumers through its stores and websites, which include the Abercrombie & Fitch, Abercrombie kids, and Hollister brands. Most stores are in the United States, but the company does have many stores in Canada, Europe, and Asia. All stores are leased. Abercrombie ships to well over 100 countries via its websites. The company sources its merchandise from dozens of vendors that are primarily located in Asia and Central America. Abercrombie has two distribution centers in Ohio to support its North American operations. It uses third-party distributors for sales in Europe and Asia.